Market Cap 3.88B
Revenue (ttm) 75.13M
Net Income (ttm) -146.41M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -194.88%
Debt to Equity Ratio 0.00
Volume 3,854,800
Avg Vol 6,896,872
Day's Range N/A - N/A
Shares Out 306.61M
Stochastic %K 70%
Beta 1.32
Analysts Strong Sell
Price Target $17.12

Company Profile

AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its lead product is ABCL635, an non-hormonal medicine, which is in Phase 2 clinical trial to treat moderate-to-severe vasomotor symptoms; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in in a Phase 1 clinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a researc...

Industry: Biotechnology
Sector: Healthcare
Phone: 604 559 9005
Address:
150 W 4th Avenue, Vancouver, Canada
Stocktradesmoon
Stocktradesmoon Sep. 24 at 7:41 AM
$ABCL 😮 🤯 PART 2/2 This time, it's not about buying a finished drug candidate. 🎯 Henlius designates the target → Amberstone creates the TCE using its own platform → And hands over the preclinical candidate. Just a few days ago, GSK bought Chimagen's finished TCE candidate, Roche bet on Dualitas's bispecific discovery technology, And Jazz custom-ordered a multispecific TCE from ABCL. The forms may differ, but the flow seems to be one and the same. "You don't need to make everything in-house. If there's good technology and a good engine, you bring it in from outside." Biotech technology deals have been quite active lately. In this environment, the one important thing for ABCL is ultimately this. Proving that they have good technology through actual candidates and milestones. 🧬👀 https://henlius.com/en/newsd/0/31578.html
0 · Reply
Stocktradesmoon
Stocktradesmoon Sep. 24 at 4:59 AM
$ABCL 🔥 Biotech is the next memory. And now imagine $ABCL with the market cap of $MRNA And of course… well, it keeps going up $ABCL. If the executives and CFO themselves are telling you with their actions what you need to do. Well, the one who catches on does it. And as a Reminder, the IPO was in December at $20 and on the first day it closed at $77. 😮 🤯 Zero doubt that it will surpass those levels‼️ This is peak macro uncertainty: rates, bond yields, inflation and war. The market is trading headlines instead of businesses. But this will pass! I’m Loading! Eventually, investors will go back to caring about contracts, revenue, clinical data and execution not what the Fed, bonds or the next geopolitical headline might do. We are going GLOBAL. Hansen’s vision for $ABCL is playing out in real time. Love this company & happy to be an Owner! 🚨Carl is locked in...we don't have enough shares. He basically laughed off phase3 not being successful... It's green lights ahead baby
3 · Reply
Stocktradesmoon
Stocktradesmoon Sep. 24 at 4:43 AM
$ABCL 👀 UPGRADE NEWS OUT‼️ 🧬 ABCL — Cantor Raises price target to $20.🚀 $ABCL already printed the goods: ABCL635 cut Hot-Flash frequency 83% vs 33% placebo — every endpoint p<0.001. Truist went $12$30 the same day. Oct 1 is the Rio presentation 📊!The real catalyst: the 12-week data. 😮 🤯 $ABCL can’t imagine you plan a menopause therapeutic data release at the 2026 IMS World Menopause conference to share bad results! We are consolidating for another move higher into the $15.29–$17.89 range. Sitting tight and accumulating long positions during price weakness—or consistently DCAing—is the best strategy from here. In the long run, ABCL will reach much higher prices. 🔥 Everyday chart just looks better and better! My conviction for $ABCL grows more and more everyday. “We have the proverbial goose in place, and now it is time for some golden eggs.” -CARL HANSEN 🚨A company that is accelerating does exactly what this post is all about. Look 👀 at the attachments below 👇🏻
0 · Reply
Stocktradesmoon
Stocktradesmoon Sep. 23 at 10:23 PM
$ABCL Someone just bought about 600,000 Shares of ABCL After hours just a few minutes ago pushing us to a NEW DAY HIGH of $12.44 Post Market (afterhours)!! BOOM!! 💥 🚀 😮 🤯 👀 at LEVEL II About $7,500,000 Million dollars and some change. f****** insane‼️ This clearly is letting us know that something will be out Pre-Market hours tomorrow! Somebody knows something!! Something has Leaked!! Get in Now or be left OUT!! -Partnership?? -12 Week Data 📊 before the Largest 2026 IMS Menopause Conference in a few days?? Carl loves to burn 🔥 the shit of the SHORTS!! What could it be?? No ONE buys that huge of a bulk of shares without knowing something! Something clearly has been inked 🖋️ and signed ✍️ !!
0 · Reply
Stocktradesmoon
Stocktradesmoon Sep. 23 at 10:02 PM
$ABCL 👏 $ABCL PHASE II Results were so “IMPRESSIVE”! Now we are Presenting at the Largest in the WORLD 🌎 🗺️ .. 2026 IMS MENOPAUSE Convention Conference in a few days‼️ We are Presenting the Phase II Results the 12 WEEK DATA 📊 (that a HUGE “f******* DEAL”) Wait until the WORLD HEARS about this… you thought the Move for Phase II results were BIG…😂 $ABCL Is going to GO Up so much in Price..it’s going to RUN for MONTHS!! $25-$30’sss 🚨Now we are going to have the ENTIRE WORLD KNOWING about US! Can you imagine how many new investors will be adding $ABCL into their portfolios?!!! This is going to be the “BIG MOVE we all been waiting for”!! This is happening Right now and after the conference‼️ **So much SMART Money will be invested and POURED into $ABCL and in the biotech sector it’s just so f*****🔥 Right now!! 🤯 The more the platform thesis gets validated, the less this looks like a long shot and the more it looks like a compounder. Risk keeps coming down!The outlook gets better!
0 · Reply
Stocktradesmoon
Stocktradesmoon Sep. 23 at 9:58 PM
$ABCL NO ONE is really SELLING. Slim trading range, as we prepare for the Next Leg UP! Don’t be a SUCKER and SELL‼️ $ABCL Sold off with $XBI and most of Market today. Bright side: 1. Volume came in lighter than yesterday. 2. Awesome 👏 buying opportunity Glad we finally tagged $13. Now waiting on Mr. $17-$20’ss. If you own biotech stocks, watch $XBI XBI is the SPDR Biotech ETF, holding a broad basket of biotech companies. Think of it as a quick gauge of overall biotech sentiment. If your stock drops 3% but XBI is also down 3%, that’s important context—(it’s macro related) I always compare individual biotech moves to $XBI. It helps separate “something is wrong with my stock” from “biotech is getting sold today.” $XBI = the biotech market thermometer. Today, $ABCL $XBI are both down about 3%. Nothing is wrong here. All sectors are down. In fact, considering we had such a good day yesterday, holding with $XBI should be viewed as a win! $XBI will bounce tomorrow so will $ABCL
0 · Reply
Stocktradesmoon
Stocktradesmoon Sep. 23 at 7:27 PM
$ABCL 👏 $ABCL PHASE II Results were so “IMPRESSIVE”! Now we are Presenting at the Largest in the WORLD 🌎 🗺️ .. 2026 IMS MENOPAUSE Convention Conference in a few days‼️ We are Presenting the Phase II Results the 12 WEEK DATA 📊 (that a HUGE “f******* DEAL”) Wait until the WORLD HEARS about this… you thought the Move for Phase II results were BIG…😂 $ABCL Is going to GO Up so much in Price..it’s going to RUN for MONTHS!! $25-$30’sss 🚨Now we are going to have the Enntire World knowing about US! Can you imagine how many new investors will be adding $ABCL into their portfolios?!!! This is going to be the “BIG MOVE we all been waiting for”!! This is happening Right now and after the conference‼️ **So much SMART Money will be invested and POURED into $ABCL and in the biotech sector its just so 🔥 Right now!! 🤯 The more the platform thesis gets validated, the less this looks like a long shot and the more it looks like a compounder. Risk keeps coming down. The outlook gets better.
0 · Reply
Stocktradesmoon
Stocktradesmoon Sep. 23 at 7:23 PM
$ABCL PHASE II Results were so “IMPRESSIVE”! Now we are Presenting at the Largest in the WORLD 🌎 🗺️ .. 2026 IMS MENOPAUSE Convention Conference in a few days‼️ We are Presenting the Phase II Results the 12 WEEK DATA 📊 (that a HUGE “f******* DEAL”) Wait until the WORLD HEARS about this… you thought the Move for Phase II results were BIG…😂 $ABCL Is going to GO Up so much in Price..it’s going to RUN for MONTHS!! $25-$30’sss 🚨Now we are going to have the Entite World knowing about US! Can you imagine how many new investors will be adding $ABCL into their portfolios?!!! This is going to be the “BIG MOVE we all been waiting for”!! This is happening Right now and after the conference‼️ **So much SMART Money will be invested and POURED into $ABCL and in the biotech sector its just so 🔥 Right now!! 🤯 The more the platform thesis gets validated, the less this looks like a long shot and the more it looks like a compounder. Risk keeps coming down. The outlook keeps getting better.
0 · Reply
Rastafari
Rastafari Sep. 23 at 7:21 PM
$ABCL it’s good to see that no one is really selling. Slim trading range, as we prepare for the next leg up! Don’t be a sucker and sell!
0 · Reply
Targhee
Targhee Sep. 23 at 5:51 PM
$ABCL volume is pathetic
0 · Reply
Latest News on ABCL
AbCellera rises 17.0%

2026-08-25T16:06:05.000Z - 4 weeks ago

AbCellera rises 17.0%


AbCellera rises 10.7%

2026-08-25T14:06:36.000Z - 4 weeks ago

AbCellera rises 10.7%


AbCellera announces $200M common stock, warrants offering

2026-08-11T20:05:47.000Z - 6 weeks ago

AbCellera announces $200M common stock, warrants offering


AbCellera price target raised to $30 from $12 at Truist

2026-08-11T13:35:37.000Z - 6 weeks ago

AbCellera price target raised to $30 from $12 at Truist


AbCellera Biologics Slides: Corporate presentation

Aug 10, 2026, 8:00 AM EDT - 6 weeks ago

AbCellera Biologics Slides: Corporate presentation


AbCellera Biologics Transcript: Study result

Aug 10, 2026, 7:30 AM EDT - 6 weeks ago

AbCellera Biologics Transcript: Study result


AbCellera Biologics Press release: Study result

Aug 10, 2026, 7:30 AM EDT - 6 weeks ago

AbCellera Biologics Press release: Study result


AbCellera Biologics Slides: Study result

Aug 10, 2026, 7:30 AM EDT - 6 weeks ago

AbCellera Biologics Slides: Study result


AbCellera price target raised to $9 from $8 at Stifel

2026-08-06T12:20:50.000Z - 6 weeks ago

AbCellera price target raised to $9 from $8 at Stifel


AbCellera Biologics Earnings Call Transcript: Q2 2026

Aug 5, 2026, 5:00 PM EDT - 7 weeks ago

AbCellera Biologics Earnings Call Transcript: Q2 2026


AbCellera Biologics Slides: Q2 2026

Aug 5, 2026, 5:00 PM EDT - 7 weeks ago

AbCellera Biologics Slides: Q2 2026


AbCellera Biologics Earnings release: Q2 2026

Aug 5, 2026, 5:00 PM EDT - 7 weeks ago

AbCellera Biologics Earnings release: Q2 2026


AbCellera Biologics Quarterly report: Q2 2026

Aug 5, 2026, 5:00 PM EDT - 7 weeks ago

AbCellera Biologics Quarterly report: Q2 2026


AbCellera Reports Q2 2026 Business Results

Aug 5, 2026, 4:05 PM EDT - 7 weeks ago

AbCellera Reports Q2 2026 Business Results


AbCellera upgraded to Buy from Hold at Benchmark

2026-07-07T10:35:14.000Z - 2 months ago

AbCellera upgraded to Buy from Hold at Benchmark

JAZZ


AbCellera Appoints Dr. Lynn Seely to its Board of Directors

Jul 6, 2026, 9:00 AM EDT - 2 months ago

AbCellera Appoints Dr. Lynn Seely to its Board of Directors


AbCellera Appoints Dr. Victor Sandor to its Board of Directors

Jun 5, 2026, 9:00 AM EDT - 3 months ago

AbCellera Appoints Dr. Victor Sandor to its Board of Directors


AbCellera Biologics Earnings Call Transcript: Q1 2026

May 11, 2026, 5:00 PM EDT - 4 months ago

AbCellera Biologics Earnings Call Transcript: Q1 2026


AbCellera Biologics Earnings release: Q1 2026

May 11, 2026, 5:00 PM EDT - 4 months ago

AbCellera Biologics Earnings release: Q1 2026


AbCellera Biologics Quarterly report: Q1 2026

May 11, 2026, 5:00 PM EDT - 4 months ago

AbCellera Biologics Quarterly report: Q1 2026


AbCellera Biologics Slides: Q1 2026

May 11, 2026, 5:00 PM EDT - 4 months ago

AbCellera Biologics Slides: Q1 2026


AbCellera Biologics Slides: Corporate presentation

May 1, 2026, 8:00 AM EDT - 4 months ago

AbCellera Biologics Slides: Corporate presentation


AbCellera Biologics Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 4 months ago

AbCellera Biologics Proxy statement: Proxy filing


AbCellera Biologics Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 4 months ago

AbCellera Biologics Proxy statement: Proxy filing


AbCellera Biologics Earnings Call Transcript: Q4 2025

Feb 24, 2026, 5:00 PM EST - 7 months ago

AbCellera Biologics Earnings Call Transcript: Q4 2025


AbCellera Biologics Annual report: Q4 2025

Feb 24, 2026, 5:00 PM EST - 7 months ago

AbCellera Biologics Annual report: Q4 2025


AbCellera Biologics Earnings release: Q4 2025

Feb 24, 2026, 5:00 PM EST - 7 months ago

AbCellera Biologics Earnings release: Q4 2025


AbCellera Biologics Slides: Q4 2025

Feb 24, 2026, 5:00 PM EST - 7 months ago

AbCellera Biologics Slides: Q4 2025


AbCellera Reports Full Year 2025 Business Results

Feb 24, 2026, 4:05 PM EST - 7 months ago

AbCellera Reports Full Year 2025 Business Results


AbCellera Biologics Slides: Corporate presentation

Jan 14, 2026, 7:00 AM EST - 8 months ago

AbCellera Biologics Slides: Corporate presentation


AbCellera Biologics Transcript: Stifel 2025 Healthcare Conference

Nov 13, 2025, 8:00 AM EST - 10 months ago

AbCellera Biologics Transcript: Stifel 2025 Healthcare Conference


AbCellera Appoints Dr. Stephen Quake to its Board of Directors

Nov 10, 2025, 9:00 AM EST - 10 months ago

AbCellera Appoints Dr. Stephen Quake to its Board of Directors


AbCellera Biologics Earnings Call Transcript: Q3 2025

Nov 6, 2025, 5:00 PM EST - 10 months ago

AbCellera Biologics Earnings Call Transcript: Q3 2025


AbCellera Biologics Quarterly report: Q3 2025

Nov 6, 2025, 5:00 PM EST - 10 months ago

AbCellera Biologics Quarterly report: Q3 2025


AbCellera Biologics Earnings release: Q3 2025

Nov 6, 2025, 5:00 PM EST - 10 months ago

AbCellera Biologics Earnings release: Q3 2025


AbCellera Biologics Slides: Q3 2025

Nov 6, 2025, 5:00 PM EST - 10 months ago

AbCellera Biologics Slides: Q3 2025


AbCellera Reports Q3 2025 Business Results

Nov 6, 2025, 4:05 PM EST - 10 months ago

AbCellera Reports Q3 2025 Business Results


AbCellera Biologics Earnings Call Transcript: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q2 2025


AbCellera Biologics Quarterly report: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Quarterly report: Q2 2025


AbCellera Biologics Earnings release: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings release: Q2 2025


AbCellera Biologics Slides: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Slides: Q2 2025


AbCellera Biologics Slides: Corporate Presentation

Aug 1, 2025, 7:00 AM EDT - 1 year ago

AbCellera Biologics Slides: Corporate Presentation


AbCellera Biologics Earnings Call Transcript: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q1 2025


AbCellera Biologics Earnings release: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings release: Q1 2025


AbCellera Biologics Quarterly report: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Quarterly report: Q1 2025


AbCellera Biologics Slides: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Slides: Q1 2025


AbCellera Reports Q1 2025 Business Results

May 8, 2025, 4:05 PM EDT - 1 year ago

AbCellera Reports Q1 2025 Business Results


AbCellera Biologics Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

AbCellera Biologics Proxy statement: Proxy Filing


AbCellera Biologics Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

AbCellera Biologics Proxy statement: Proxy Filing


AbCellera Biologics Earnings Call Transcript: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q4 2024


AbCellera Biologics Earnings release: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings release: Q4 2024


AbCellera Biologics Annual report: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Annual report: Q4 2024


AbCellera Biologics Slides: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Slides: Q4 2024


AbCellera Reports Full Year 2024 Business Results

Feb 27, 2025, 4:05 PM EST - 1 year ago

AbCellera Reports Full Year 2024 Business Results


AbCellera Biologics Slides: FY 2025

Jan 15, 2025, 7:30 PM EST - 1 year ago

AbCellera Biologics Slides: FY 2025


AbCellera Biologics Earnings Call Transcript: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q3 2024


AbCellera Biologics Quarterly report: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Quarterly report: Q3 2024


AbCellera Biologics Earnings release: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings release: Q3 2024


AbCellera Biologics Slides: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Slides: Q3 2024


AbCellera Reports Q3 2024 Business Results

Nov 4, 2024, 4:05 PM EST - 1 year ago

AbCellera Reports Q3 2024 Business Results


Stocktradesmoon
Stocktradesmoon Sep. 24 at 7:41 AM
$ABCL 😮 🤯 PART 2/2 This time, it's not about buying a finished drug candidate. 🎯 Henlius designates the target → Amberstone creates the TCE using its own platform → And hands over the preclinical candidate. Just a few days ago, GSK bought Chimagen's finished TCE candidate, Roche bet on Dualitas's bispecific discovery technology, And Jazz custom-ordered a multispecific TCE from ABCL. The forms may differ, but the flow seems to be one and the same. "You don't need to make everything in-house. If there's good technology and a good engine, you bring it in from outside." Biotech technology deals have been quite active lately. In this environment, the one important thing for ABCL is ultimately this. Proving that they have good technology through actual candidates and milestones. 🧬👀 https://henlius.com/en/newsd/0/31578.html
0 · Reply
Stocktradesmoon
Stocktradesmoon Sep. 24 at 4:59 AM
$ABCL 🔥 Biotech is the next memory. And now imagine $ABCL with the market cap of $MRNA And of course… well, it keeps going up $ABCL. If the executives and CFO themselves are telling you with their actions what you need to do. Well, the one who catches on does it. And as a Reminder, the IPO was in December at $20 and on the first day it closed at $77. 😮 🤯 Zero doubt that it will surpass those levels‼️ This is peak macro uncertainty: rates, bond yields, inflation and war. The market is trading headlines instead of businesses. But this will pass! I’m Loading! Eventually, investors will go back to caring about contracts, revenue, clinical data and execution not what the Fed, bonds or the next geopolitical headline might do. We are going GLOBAL. Hansen’s vision for $ABCL is playing out in real time. Love this company & happy to be an Owner! 🚨Carl is locked in...we don't have enough shares. He basically laughed off phase3 not being successful... It's green lights ahead baby
3 · Reply
Stocktradesmoon
Stocktradesmoon Sep. 24 at 4:43 AM
$ABCL 👀 UPGRADE NEWS OUT‼️ 🧬 ABCL — Cantor Raises price target to $20.🚀 $ABCL already printed the goods: ABCL635 cut Hot-Flash frequency 83% vs 33% placebo — every endpoint p<0.001. Truist went $12$30 the same day. Oct 1 is the Rio presentation 📊!The real catalyst: the 12-week data. 😮 🤯 $ABCL can’t imagine you plan a menopause therapeutic data release at the 2026 IMS World Menopause conference to share bad results! We are consolidating for another move higher into the $15.29–$17.89 range. Sitting tight and accumulating long positions during price weakness—or consistently DCAing—is the best strategy from here. In the long run, ABCL will reach much higher prices. 🔥 Everyday chart just looks better and better! My conviction for $ABCL grows more and more everyday. “We have the proverbial goose in place, and now it is time for some golden eggs.” -CARL HANSEN 🚨A company that is accelerating does exactly what this post is all about. Look 👀 at the attachments below 👇🏻
0 · Reply
Stocktradesmoon
Stocktradesmoon Sep. 23 at 10:23 PM
$ABCL Someone just bought about 600,000 Shares of ABCL After hours just a few minutes ago pushing us to a NEW DAY HIGH of $12.44 Post Market (afterhours)!! BOOM!! 💥 🚀 😮 🤯 👀 at LEVEL II About $7,500,000 Million dollars and some change. f****** insane‼️ This clearly is letting us know that something will be out Pre-Market hours tomorrow! Somebody knows something!! Something has Leaked!! Get in Now or be left OUT!! -Partnership?? -12 Week Data 📊 before the Largest 2026 IMS Menopause Conference in a few days?? Carl loves to burn 🔥 the shit of the SHORTS!! What could it be?? No ONE buys that huge of a bulk of shares without knowing something! Something clearly has been inked 🖋️ and signed ✍️ !!
0 · Reply
Stocktradesmoon
Stocktradesmoon Sep. 23 at 10:02 PM
$ABCL 👏 $ABCL PHASE II Results were so “IMPRESSIVE”! Now we are Presenting at the Largest in the WORLD 🌎 🗺️ .. 2026 IMS MENOPAUSE Convention Conference in a few days‼️ We are Presenting the Phase II Results the 12 WEEK DATA 📊 (that a HUGE “f******* DEAL”) Wait until the WORLD HEARS about this… you thought the Move for Phase II results were BIG…😂 $ABCL Is going to GO Up so much in Price..it’s going to RUN for MONTHS!! $25-$30’sss 🚨Now we are going to have the ENTIRE WORLD KNOWING about US! Can you imagine how many new investors will be adding $ABCL into their portfolios?!!! This is going to be the “BIG MOVE we all been waiting for”!! This is happening Right now and after the conference‼️ **So much SMART Money will be invested and POURED into $ABCL and in the biotech sector it’s just so f*****🔥 Right now!! 🤯 The more the platform thesis gets validated, the less this looks like a long shot and the more it looks like a compounder. Risk keeps coming down!The outlook gets better!
0 · Reply
Stocktradesmoon
Stocktradesmoon Sep. 23 at 9:58 PM
$ABCL NO ONE is really SELLING. Slim trading range, as we prepare for the Next Leg UP! Don’t be a SUCKER and SELL‼️ $ABCL Sold off with $XBI and most of Market today. Bright side: 1. Volume came in lighter than yesterday. 2. Awesome 👏 buying opportunity Glad we finally tagged $13. Now waiting on Mr. $17-$20’ss. If you own biotech stocks, watch $XBI XBI is the SPDR Biotech ETF, holding a broad basket of biotech companies. Think of it as a quick gauge of overall biotech sentiment. If your stock drops 3% but XBI is also down 3%, that’s important context—(it’s macro related) I always compare individual biotech moves to $XBI. It helps separate “something is wrong with my stock” from “biotech is getting sold today.” $XBI = the biotech market thermometer. Today, $ABCL $XBI are both down about 3%. Nothing is wrong here. All sectors are down. In fact, considering we had such a good day yesterday, holding with $XBI should be viewed as a win! $XBI will bounce tomorrow so will $ABCL
0 · Reply
Stocktradesmoon
Stocktradesmoon Sep. 23 at 7:27 PM
$ABCL 👏 $ABCL PHASE II Results were so “IMPRESSIVE”! Now we are Presenting at the Largest in the WORLD 🌎 🗺️ .. 2026 IMS MENOPAUSE Convention Conference in a few days‼️ We are Presenting the Phase II Results the 12 WEEK DATA 📊 (that a HUGE “f******* DEAL”) Wait until the WORLD HEARS about this… you thought the Move for Phase II results were BIG…😂 $ABCL Is going to GO Up so much in Price..it’s going to RUN for MONTHS!! $25-$30’sss 🚨Now we are going to have the Enntire World knowing about US! Can you imagine how many new investors will be adding $ABCL into their portfolios?!!! This is going to be the “BIG MOVE we all been waiting for”!! This is happening Right now and after the conference‼️ **So much SMART Money will be invested and POURED into $ABCL and in the biotech sector its just so 🔥 Right now!! 🤯 The more the platform thesis gets validated, the less this looks like a long shot and the more it looks like a compounder. Risk keeps coming down. The outlook gets better.
0 · Reply
Stocktradesmoon
Stocktradesmoon Sep. 23 at 7:23 PM
$ABCL PHASE II Results were so “IMPRESSIVE”! Now we are Presenting at the Largest in the WORLD 🌎 🗺️ .. 2026 IMS MENOPAUSE Convention Conference in a few days‼️ We are Presenting the Phase II Results the 12 WEEK DATA 📊 (that a HUGE “f******* DEAL”) Wait until the WORLD HEARS about this… you thought the Move for Phase II results were BIG…😂 $ABCL Is going to GO Up so much in Price..it’s going to RUN for MONTHS!! $25-$30’sss 🚨Now we are going to have the Entite World knowing about US! Can you imagine how many new investors will be adding $ABCL into their portfolios?!!! This is going to be the “BIG MOVE we all been waiting for”!! This is happening Right now and after the conference‼️ **So much SMART Money will be invested and POURED into $ABCL and in the biotech sector its just so 🔥 Right now!! 🤯 The more the platform thesis gets validated, the less this looks like a long shot and the more it looks like a compounder. Risk keeps coming down. The outlook keeps getting better.
0 · Reply
Rastafari
Rastafari Sep. 23 at 7:21 PM
$ABCL it’s good to see that no one is really selling. Slim trading range, as we prepare for the next leg up! Don’t be a sucker and sell!
0 · Reply
Targhee
Targhee Sep. 23 at 5:51 PM
$ABCL volume is pathetic
0 · Reply
Stocktradesmoon
Stocktradesmoon Sep. 23 at 5:02 PM
$ABCL $ABCL like 635 is DONE ✅ DEAL and it’s a matter of time before REVENUE STARTS FLOWING!!! Get in NOW and BUY ALL you CAN here $12.30’ss/$12.40’sss we heading to $13’sss today!! 👏 😮 🤯 We got the Largest in the WORLD 🌍 🗺️ 2026 IMS Menopause Convention Conference in a few days!!! After such an IMPRESSIVE Phase II RESULTS we are are now about to Get the 12 WEEK DATA 📊 This is a “BIG” Deal we about to go to $17’ss to $20’sss real fast! $ABCL 🚨 can’t imagine you plan a menopause therapeutic data release at the 2026 IMS World Menopause conference to share bad results! 🤩
0 · Reply
Stocktradesmoon
Stocktradesmoon Sep. 23 at 4:38 PM
$ABCL Take Advantage of these Discount Prices $12.30’ss-$12.40’sss! ⚠️REMEMBER Market Conditions are just Temporary and will be forgotten by this afternoon when we are SUPER GREEN‼️ 🔥 People got to understand that when market conditions are red the thesis of $ABCL is still intact. NOTHING has CHANGED! These conditions offer us some really good discounts however they don’t last very LONG! We got a MAJOR CATALYST in a few days. It’s the LARGEST 2026 IMS Menopause Convention Conference in the world 🌍 🗺️!! 🚨There they are going to Release Phase II 12 WEEK DATA 📊!! This a Really big “DEAL”!!! It’s the 90 days following the Very IMPRESSIVE Phase II RESULTS!! You want to buy ALL you can NOW!! We are going to start Moving Much…Much…HIGHER!!
1 · Reply
Quadruple_Double
Quadruple_Double Sep. 23 at 4:34 PM
$ABCL the r*tar* is back ladie and gentlemen. When it is down he's crying like a baby that why won't it go up?, and when we are up he's saying he wants it down. Absolute mental illness..
1 · Reply
tradersunion353
tradersunion353 Sep. 23 at 3:56 PM
$ABCL before droppping to 9.50s this is not making any further upward moves buy order set to 9.50
0 · Reply
Stocktradesmoon
Stocktradesmoon Sep. 23 at 3:45 PM
$ABCL Take Advantage of these Discount Prices $12.30’ss-$12.40’sss! ⚠️REMEMBER Market Conditions are just Temporary and will be forgotten by this afternoon when we are SUPER GREEN‼️ 🔥 People got to understand that when market conditions are red the thesis of $ABCL is still intact. NOTHING has CHANGED! These conditions offer us some really good discounts however they don’t last very LONG! We got a MAJOR CATALYST in a few days. It’s the LARGEST 2026 IMS Menopause Convention Conference in the world 🌍 🗺️!! 🚨There they are going to Release Phase II 12 WEEK DATA 📊!! This a Really big “DEAL”!!! It’s the 90 days following the Very IMPRESSIVE Phase II RESULTS!! You want to buy ALL you can NOW!! We are going to start Moving Much…Much…HIGHER!!
0 · Reply
Stocktradesmoon
Stocktradesmoon Sep. 23 at 3:04 PM
$ABCL I’m Buying all I can!! Just ADDED 10,000 more shares! You Should too! $12.30’ss is a gift 🎁!! MM’s and Shorts are trying to SCARE you by painting the tape RED!! It’s Old tricks!! We will be at $13’ss by this afternoon!! $ABCL got’s too much going for it!! I can’t get enough shares!!! $ABCL 🚨We about to hear the Phase II 12 WEEK DATA 📊 in a few days at the LARGEST IMS MENOPAUSE 2026 Convention CONFERENCE!! We already know that CEO Carl and Management had HUGE PHASE II Results! Really IMPRESSIVE!! Carl in his own words said “Patients were CURED” yes you read that right “CURED”. Patients experiencing 10 Events a day went to “ZERO” in less than 4 weeks!!! 😮 🤯 🚨We going to START MOVING Much..Much..HIGHER!! 👀 at the HIRING they are doing!! Look Pictures attached!
0 · Reply
Stocktradesmoon
Stocktradesmoon Sep. 23 at 2:18 PM
$ABCL YES! 👏 Just ADDED 10,000 more shares @12.40’s!! I know where this is heading! We will be in the 13’sss by this afternoon. Look 👀 at this Chart 📈 it’s SCREAMING $17’sss-$20’s
0 · Reply
Stocktradesmoon
Stocktradesmoon Sep. 23 at 1:47 PM
$ABCL $17’ss-$20’sss by next week!! 😮 🤯 Carl Hansen’s vision for $ABCL is becoming clearer. Build the Engine → build the pipeline → prove it clinically → commercialize. 🚨Now AbCellera is hiring a VP of Medical Affairs to support ABCL635, Phase 3 planning AND commercial launch‼️ The transition is happening!! 🚀
1 · Reply
Targhee
Targhee Sep. 23 at 1:45 PM
$ABCL algo’s working hard this am
0 · Reply
Stocktradesmoon
Stocktradesmoon Sep. 23 at 1:43 PM
$ABCL PART 1/1 🧬💰 A $560T Patent Cliff Is Coming. According to the attached Reuters Breakingviews article, **the revenue from pharmaceuticals with patents expiring by 2033 is approximately $400B (about 560 trillion won)**. 📉 Big Pharma companies like Novo Nordisk, AstraZeneca, Merck, J&J, GSK, Novartis, and others are facing patent cliffs one after another. ⏳ However, securing replacement new drugs isn't easy either. 🧪 In-House R&D The projected return on late-stage pipelines has fallen from a historical average of 11% to about 9% in 2026. It's now nearly matching the cost of capital at 8%. 💸 Biotech M&A While the risk of failure decreases, good assets are already too expensive. With Big Pharma competing against each other, acquisition premiums are also skyrocketing. In that case, one option becomes all the more crucial.
0 · Reply
Stocktradesmoon
Stocktradesmoon Sep. 23 at 1:41 PM
$ABCL PART 2/2 🎯 "Let's secure good new drug candidates earlier." This is exactly where the partnership landscape for new drug discovery platforms like AbCellera could actually improve. 🤝🧬 📉 Patents are expiring 📉 In-house R&D efficiency is declining 📈 Prices for finished biotechs are rising. In that scenario, the value of partners who can create good candidates earlier and more efficiently has no choice but to increase. From the perspective of Big Pharma's headaches, it's the very problem $ABCL is aiming to solve. 🎯 😮 🤯
0 · Reply
Stocktradesmoon
Stocktradesmoon Sep. 23 at 1:28 PM
$ABCL 🚨🚨 👀 We are going to $17-20’ssss‼️
0 · Reply